Patents matching “inhibitor”

US 6376515

Benzamides and related inhibitors of factor Xa

COR Therapeutics, Inc. · Granted Apr 23, 2002 · Expires Apr 18, 2022

US 6375946

Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor

Maxim Pharmaceuticals, Inc. · Granted Apr 23, 2002 · Expires Apr 18, 2022

US 6376467

Use of inhibitors of protein kinase C epsilon to treat pain

The Regents of the University of California · Granted Apr 23, 2002 · Expires Apr 18, 2022

US 6372778

Sulfonamide inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated · Granted Apr 16, 2002 · Expires Apr 11, 2022

US 6369063

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Apr 9, 2002 · Expires Apr 4, 2022

US 6369080

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Apr 9, 2002 · Expires Apr 4, 2022

US 6365359

Inhibitors of prion formation

The Regents of the University of California · Granted Apr 2, 2002 · Expires Mar 28, 2022

US 6355610

Inhibitors of formation of protease resistant prion protein

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 12, 2002 · Expires Mar 7, 2022

US 6355619

Peptide tumor cell growth inhibitors

The Board of Regents of the University of Texas System · Granted Mar 12, 2002 · Expires Mar 7, 2022

US 6353097

Nucleic acids encoding signal transduction inhibitors of allergic reactions

The United States of America, as represented by the Department of Health and Human Services · Granted Mar 5, 2002 · Expires Feb 28, 2022

US 6350741

Inhibitors of interleukin-1&bgr; converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Feb 26, 2002 · Expires Feb 21, 2022

US 6350785

Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors

Maxim Pharmaceuticals, Inc. · Granted Feb 26, 2002 · Expires Feb 21, 2022

US 6344465

Inhibitors of IMPDH enzyme

Vertex Pharmaceuticals Incorporated · Granted Feb 5, 2002 · Expires Jan 31, 2022

US 6333033

Autoantibody inhibitors

The Regents of the University of California · Granted Dec 25, 2001 · Expires Dec 20, 2021

US 6333321

Selective factor Xa inhibitors

COR Therapeutics, Inc. · Granted Dec 25, 2001 · Expires Dec 20, 2021

US 6329365

Inhibitors of interleukin-1.beta. converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Dec 11, 2001 · Expires Dec 6, 2021

US 6323226

Treatment of heart disease with cox-2 inhibitors

The Board of Regents of the University of Texas System · Granted Nov 27, 2001 · Expires Nov 22, 2021

US 6319946

Inhibitors of aspartyl protease

Vertex Pharmaceuticals Incorporated · Granted Nov 20, 2001 · Expires Nov 15, 2021

US 6310107

Amine compounds, their production and use as amyloid-.beta. production inhibitors

Takeda Chemical Industries Ltd. · Granted Oct 30, 2001 · Expires Oct 25, 2021

US 6310088

Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity

Darwin Discovery Limited · Granted Oct 30, 2001 · Expires Oct 25, 2021

US 6291664

Method of eliminating inhibitory/instability regions of mRNA

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 18, 2001 · Expires Sep 13, 2021

US 6291469

Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation

COR Therapeutics, Inc. · Granted Sep 18, 2001 · Expires Sep 13, 2021

US 6281196

Isolation and structural elucidation of the human cancer cell growth inhibitory compound denominated agelagalastatin

THE ARIZONA BOARD OF REGENTS · Granted Aug 28, 2001 · Expires Aug 23, 2021

US 6277827

Single morphic forms of metalloproteinase inhibitors

Darwin Discovery Limited · Granted Aug 21, 2001 · Expires Aug 16, 2021